| Literature DB >> 36110573 |
Yahui Li1, Jing Wu2, Gehong Zhu1.
Abstract
Objective: To determine the effectiveness of comprehensive nursing in the care of ovarian carcinoma (OC) patients treated with paclitaxel (PTX) plus nedaplatin (NDP).Entities:
Mesh:
Substances:
Year: 2022 PMID: 36110573 PMCID: PMC9470341 DOI: 10.1155/2022/9398823
Source DB: PubMed Journal: Comput Math Methods Med ISSN: 1748-670X Impact factor: 2.809
Patient's general information.
| Classification | Observation group ( | Control group ( |
|
|
|---|---|---|---|---|
| Mean age (years) | 48.11 ± 6.92 | 48.84 ± 6.46 | 0.72 | 0.470 |
| BMI | 27.34 ± 1.62 | 27.29 ± 1.39 | 0.22 | 0.827 |
| Drinking | 0.09 | 0.769 | ||
| Yes | 72 (72.00) | 56 (70.00) | ||
| No | 28 (28.00) | 24 (30.00) | ||
| Smoking | 0.01 | 0.919 | ||
| Yes | 88 (88.00) | 70 (87.50) | ||
| No | 12 (12.00) | 10 (12.50) | ||
| Working state | 1.42 | 0.233 | ||
| Employed | 78 (78.00) | 68 (85.00) | ||
| Unemployed | 22 (22.00) | 12 (15.00) | ||
| Family type | 2.51 | 0.113 | ||
| Nuclear family | 64 (64.00) | 60 (75.00) | ||
| Others | 36 (36.00) | 20 (25.00) | ||
| Place of residence | 0.01 | 0.945 | ||
| Rural | 37 (37.00) | 30 (37.50) | ||
| Urban | 63 (63.00) | 50 (62.50) |
Figure 1Serum levels of NGF, TK1, and CA15-3 in the two groups: (a) serum NGF levels before and after nursing in the two groups. (b) Serum TK1 levels in the two groups before and after nursing. (c) Serum CA15-3 levels before and after nursing in the two groups. Note: #P < 0.05 vs. before treatment; ∗P < 0.05 vs. control group.
Figure 2Mental health of patients in the two groups: (a) SAS scores before and after nursing in the two groups. (b) SDS scores of the two groups before and after nursing. Note: #P < 0.05 vs. before treatment; ∗P < 0.05 vs. control group.
Compliance of patients in the two groups.
| Classification | Observation group ( | Control group ( |
|
|
|---|---|---|---|---|
| Complete compliance | 73 (73.00) | 36 (45.00) | — | — |
| Partial compliance | 24 (24.00) | 24 (30.00) | — | — |
| Noncompliance | 3 (3.00) | 20 (25.00) | — | — |
| Total compliance (%) | 97 (97.00) | 60 (75.00) | 19.30 | <0.001 |
Incidence of adverse reactions in the two groups.
| Classification | Observation group ( | Control group ( |
|
|
|---|---|---|---|---|
| Myelosuppression | 0 (0.00) | 2 (2.50) | — | — |
| Hair loss | 2 (2.00) | 4 (5.00) | — | — |
| Gastrointestinal discomfort | 2 (2.00) | 4 (5.00) | ||
| Anemia | 0 (0.00) | 2 (2.50) | — | — |
| Total incidence (%) | 4 (4.00) | 12 (15.00) | 6.64 | 0.01 |
Nursing satisfaction of patients in the two groups.
| Classification | Observation group ( | Control group ( |
|
|
|---|---|---|---|---|
| Satisfied | 70 (70.00) | 34 (42.50) | — | — |
| Basically satisfied | 28 (28.00) | 30 (37.50) | — | — |
| Dissatisfied | 2 (2.00) | 16 (20.00) | — | — |
| Satisfaction (%) | 98 (98.00) | 64 (80.00) | 16.00 | <0.001 |